rs2293284
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005259.3(MSTN):c.374-84A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0407 in 1,230,538 control chromosomes in the GnomAD database, including 3,472 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.093 ( 1399 hom., cov: 32)
Exomes 𝑓: 0.033 ( 2073 hom. )
Consequence
MSTN
NM_005259.3 intron
NM_005259.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.23
Genes affected
MSTN (HGNC:4223): (myostatin) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein negatively regulates skeletal muscle cell proliferation and differentiation. Mutations in this gene are associated with increased skeletal muscle mass in humans and other mammals. [provided by RefSeq, Jul 2016]
C2orf88 (HGNC:28191): (chromosome 2 open reading frame 88) Predicted to enable protein kinase A regulatory subunit binding activity. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 2-190060519-T-A is Benign according to our data. Variant chr2-190060519-T-A is described in ClinVar as [Benign]. Clinvar id is 1258180.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.237 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSTN | NM_005259.3 | c.374-84A>T | intron_variant | ENST00000260950.5 | NP_005250.1 | |||
C2orf88 | XM_047446008.1 | c.-517-19435T>A | intron_variant | XP_047301964.1 | ||||
C2orf88 | XM_047446009.1 | c.-517-19435T>A | intron_variant | XP_047301965.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSTN | ENST00000260950.5 | c.374-84A>T | intron_variant | 1 | NM_005259.3 | ENSP00000260950.3 | ||||
C2orf88 | ENST00000478197.1 | n.220-18704T>A | intron_variant | 4 | ||||||
C2orf88 | ENST00000495546.1 | n.202-19435T>A | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0927 AC: 14075AN: 151892Hom.: 1396 Cov.: 32
GnomAD3 genomes
AF:
AC:
14075
AN:
151892
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0333 AC: 35956AN: 1078528Hom.: 2073 AF XY: 0.0320 AC XY: 17538AN XY: 547290
GnomAD4 exome
AF:
AC:
35956
AN:
1078528
Hom.:
AF XY:
AC XY:
17538
AN XY:
547290
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0928 AC: 14108AN: 152010Hom.: 1399 Cov.: 32 AF XY: 0.0902 AC XY: 6703AN XY: 74336
GnomAD4 genome
AF:
AC:
14108
AN:
152010
Hom.:
Cov.:
32
AF XY:
AC XY:
6703
AN XY:
74336
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
248
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at